论文部分内容阅读
卵巢肿瘤的血清标记把我科治疗的卵巢肿瘤患者的术前的血清 CA125、CEA、AFP、LDH、LDH 同功酶,按照 WHO 分类在肿瘤组织类别方面加以讨论。首先,在普通上皮细胞瘤恶性的62.5%、界限瘤25%,CA125呈现上升。按组织区别浆液性癌、子宫内膜样癌、非特异性癌几乎全是阳性,粘液性瘤几乎都是阴性。手术前 CA125上升的症例,术后即下降,再次复发时,再次上升,和临床经过很一致。生殖细胞瘤、性索-间质肿瘤 CA125全是阴性,对 Krukeulerg 瘤等转移性肿瘤少数是阳性。也就是说 CA125在卵巢肿瘤中除粘液性肿瘤以外的上皮细胞癌全被认为是比较特异的指标。关于 CEA,作为上皮瘤整体来讲,恶性瘤的40.6%,界限瘤的45.5%、良性瘤的26.9%可见上升。用组织
Serum Markers of Ovarian Tumors The preoperative serum CA125, CEA, AFP, LDH, and LDH isoenzymes in patients with ovarian cancer who were treated in our department were discussed in accordance with the WHO classification for the classification of tumor tissues. First of all, 62.5% of malignant epithelial neoplasms, borderline tumors 25%, CA125 showed an increase. Differentiated by tissue serous carcinoma, endometrioid carcinoma, almost all non-specific positive cancer, mucinous neoplasms are almost always negative. Preoperative CA125 rise in the case, that is, after the decline, once again relapse, rising again, and the clinical experience is very consistent. Germ cell tumors, sex cord stromal tumors CA125 all negative, a small number of metastatic tumors such as Krukeulerg tumor is positive. That CA125 in ovarian tumors in addition to mucinous tumors other than epithelial cell carcinoma is considered to be more specific indicators. About CEA, 40.6% of malignant tumors, 45.5% of borderline tumors, and 26.9% of benign tumors showed an increase as a whole as an epithelial tumor. With tissue